The shares of the prominent ethanol producer hit 20 percent upper circuit in today’s trading session after the company’s net profit and revenue increased by 1100 percent and 30 percent QoQ, respectively, in Q4.
With a market capitalization of Rs 1,165.79 crore, the shares of Godavari Biorefineries Ltd were trading at Rs 227.80 per share, increasing around 19.99 percent as compared to the previous closing price of Rs 189.85 apiece.
Q4 Highlights
The shares of Godavari Biorefineries Ltd have seen positive movement after reporting positive Q4 results, revenue increased by 30 percent on a quarter-on-quarter basis from Rs 447 crore in Q3FY25 to Rs 580 crore in Q4FY25. Further, revenue decreased by 6 percent year on year, from Rs 615 crore in Q4FY24 to Rs 580 crore in Q4FY25.
The company’s net profit increased by 1,100 percent on a quarter-on-quarter basis, from Rs. 6 crore in Q3FY25 to Rs.72 crore in Q4FY25. Further, net profit magnified significantly by 11 percent year on year from Rs 65 crore in Q4FY24 to Rs 72 crore in Q4FY25.
The company posted a mixed FY24- 25 performance, with revenue increasing 11 percent from Rs 1,687 crore to Rs 1,870 crore. Net profit turned into a loss, from a profit of Rs 12 crore to a loss of Rs 23 crore, reflecting weak profitability over the previous financial year.
In FY25, the company reported revenue of Rs 1,870.3 crore, EBITDA of Rs 120.3 crore (6.4 percent margin), and PAT of Rs 1.1 crore (0.1 percent margin). Revenue mix includes sugar (39 percent), bio-based chemicals (29 percent), and distillery (31 percent). Geographically, 90 percent of revenue came from domestic sales, with exports contributing 10 percent.
Godavari Biorefineries is a manufacturer of ethanol-based chemicals in India, operating as an integrated bio-refinery. The company uses sugarcane as feedstock for manufacturing bio-based chemicals, sugar, various grades of ethanol, and power.
Written by Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
